Sanofi Research and Development Expense
Sanofi (SNYNF) reported Research and Development Expense of EUR 7.84 billion for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-17.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ResearchAndDevelopmentExpense · last filed 2026-02-17
| Period end | Research And Development Expense 6 month | Research And Development Expense 6 month as first filed | Research And Development Expense 12 month | Research And Development Expense 12 month as first filed |
|---|---|---|---|---|
| 2025-12-31 | 7.84B EUR 20-F · filed 2026-02-17 | |||
| 2025-06-30 | 3.72B EUR 6-K · filed 2025-10-27 | |||
| 2024-12-31 | 7.39B EUR 20-F · filed 2026-02-17 | |||
| 2024-06-30 | 3.33B EUR 6-K · filed 2025-10-27 | 3.42B EUR 6-K · filed 2024-07-25 | ||
| 2023-12-31 | 6.51B EUR 20-F · filed 2026-02-17 | 6.73B EUR 20-F · filed 2024-02-23 | ||
| 2023-06-30 | 3.19B EUR 6-K · filed 2024-07-25 | |||
| 2022-12-31 | 6.50B EUR 20-F · filed 2025-02-13 | 6.71B EUR 20-F · filed 2023-02-24 | ||
| 2022-06-30 | 3.15B EUR 6-K · filed 2023-07-28 | |||
| 2021-12-31 | 5.69B EUR 20-F · filed 2024-02-23 | |||
| 2021-06-30 | 2.66B EUR 6-K · filed 2022-07-28 | |||
| 2020-12-31 | 5.53B EUR 20-F · filed 2023-02-24 | 5.53B EUR 20-F · filed 2021-03-04 | ||
| 2020-06-30 | 2.69B EUR 6-K · filed 2021-07-29 | |||
| 2019-12-31 | 6.02B EUR 20-F · filed 2022-02-23 | 6.02B EUR 20-F · filed 2020-03-05 | ||
| 2019-06-30 | 2.97B EUR 6-K · filed 2020-07-29 | |||
| 2018-12-31 | 5.89B EUR 20-F · filed 2021-03-04 | |||
| 2017-12-31 | 5.47B EUR 20-F · filed 2020-03-05 | |||
| 2016-12-31 | 5.17B EUR 20-F · filed 2019-03-08 | |||
| 2015-12-31 | 5.08B EUR 20-F/A · filed 2018-03-16 |